Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marty, M. S.
Right arrow Articles by Carney, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marty, M. S.
Right arrow Articles by Carney, E. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 60, 285-295 (2001)
Copyright © 2001 by the Society of Toxicology

ENDOCRINE TOXICOLOGY

Evaluation of the Male Pubertal Onset Assay to Detect Testosterone and Steroid Biosynthesis Inhibitors in CD Rats

M. S. Marty,1, J. W. Crissman,2 and E. W. Carney

Toxicology and Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Midland, Michigan 48674

The male pubertal onset assay has been recommended by the Endocrine Disrupter Screening and Testing Advisory Committee (EDSTAC) as an alternate Tier I screening assay to detect potential endocrine-active chemicals (EACs). Recently, this assay was evaluated by several laboratories using a variety of dosing schemes. This study used a 30-day dosing period to confirm and extend previous work on the assay's ability to detect steroid biosynthesis inhibitors. Weanling male rats were dosed by gavage from 21 to 50 days of age with vehicle (0.5% methocel) or chemicals from the following EAC classes: an androgen (testosterone propionate [TP], 0.1 or 0.4 mg/kg/day), a broad-spectrum steroid biosynthesis inhibitor (ketoconazole [KETO], 24 mg/kg/day), a 5{alpha}-reductase inhibitor (finasteride [FIN], 20 or 80 mg/kg/day), a moderately specific aromatase inhibitor (testolactone [TL], 220 mg/kg/day), or a highly specific aromatase inhibitor (fadrozole [FAD], 0.6 or 6.0 mg/kg/day). None of these treatments altered relative thyroid weights. However, TL, KETO, and FIN were positive for endocrine activity based on decreases in one or more reproductive or accessory sex gland organ weights. Of these three inhibitors, only TL significantly increased the age at PPS, indicating that PPS was less sensitive for detecting these EACs. Based on its profile of effects, TL may have been detected as an antiandrogen. TP and FAD were negative in this assay, even at doses that caused effects in other studies. With TP, oral administration limited assay sensitivity such that higher TP doses would be needed for detection. FAD decreased body weight gains, but did not significantly alter any other assay end points; thus, the capacity of this assay to detect aromatase inhibitors remains in question.

Key Words: endocrine disruption; endocrine modulation; EDSTAC; puberty; pubertal onset; preputial separation; testosterone; steroid inhibitors; thyroid..


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EndocrinologyHome page
G. P. Finkielstain, P. Forcinito, J. C. K. Lui, K. M. Barnes, R. Marino, S. Makaroun, V. Nguyen, J. E. Lazarus, O. Nilsson, and J. Baron
An Extensive Genetic Program Occurring during Postnatal Growth in Multiple Tissues
Endocrinology, April 1, 2009; 150(4): 1791 - 1800.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
H. Tinwell, C. Friry-Santini, D. Rouquie, S. Belluco, L. Elies, C. Pallen, and R. Bars
Evaluation of the Antiandrogenic Effects of Flutamide, DDE, and Linuron in the Weanling Rat Assay Using Organ Weight, Histopathological, and Proteomic Approaches
Toxicol. Sci., November 1, 2007; 100(1): 54 - 65.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. C. Laws, T. E. Stoker, J. M. Ferrell, M. G. Hotchkiss, and R. L. Cooper
Effects of Altered Food Intake during Pubertal Development in Male and Female Wistar Rats
Toxicol. Sci., November 1, 2007; 100(1): 194 - 202.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
C. R. Blystone, J. Furr, C. S. Lambright, K. L. Howdeshell, B. C. Ryan, V. S. Wilson, G. A. LeBlanc, and L. E. Gray Jr
Prochloraz Inhibits Testosterone Production at Dosages below Those that Affect Androgen-Dependent Organ Weights or the Onset of Puberty in the Male Sprague Dawley Rat
Toxicol. Sci., May 1, 2007; 97(1): 65 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
M. Heneweer, M. Muusse, M. Dingemans, P. C. de Jong, M. van den Berg, and J. T. Sanderson
Co-culture of Primary Human Mammary Fibroblasts and MCF-7 Cells as an In Vitro Breast Cancer Model
Toxicol. Sci., February 1, 2005; 83(2): 257 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. C. O'Connor, S. R. Frame, and G. S. Ladics
Evaluation of a 15-Day Screening Assay Using Intact Male Rats for Identifying Steroid Biosynthesis Inhibitors and Thyroid Modulators
Toxicol. Sci., September 1, 2002; 69(1): 79 - 91.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
H. Tamura, K. W. Gaido, D. C. Dorman, and L. E. Gray
Reply
Toxicol. Sci., July 1, 2001; 62(1): 183 - 183.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.